Sutetinib Maleate Capsule

DRUG2 trials

Sponsors

Teligene US

Conditions

Non-small Cell Lung Cancer

Phase 2

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

RecruitingNCT05168566

Teligene USNon-small Cell Lung Cancer

Start: 2022-09-01End: 2028-12-01Target: 99Updated: 2026-04-28

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

RecruitingNCT06010329

Teligene USNon-small Cell Lung Cancer

Start: 2023-12-27End: 2028-12-01Target: 66Updated: 2026-04-24

Related Papers

Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.

2026-08-24